Martin P. Sutter - Nov 15, 2022 Form 4 Insider Report for ABIOMED INC (NASD)

Role
Director
Signature
/s/ Marc A Began (by power of attorney)
Stock symbol
NASD
Transactions as of
Nov 15, 2022
Transactions value $
-$1,498,458
Form type
4
Date filed
11/17/2022, 03:05 PM
Previous filing
Aug 17, 2022
Next filing
Dec 27, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NASD Common Stock, $0.01 par value Sale -$424K -1.13K -0.92% $374.18* 122K Nov 15, 2022 Direct F1, F2
transaction NASD Common Stock, $0.01 par value Sale -$325K -867 -0.71% $374.92* 121K Nov 15, 2022 Direct F1, F3
transaction NASD Common Stock, $0.01 par value Sale -$696K -1.86K -1.53% $374.66* 120K Nov 16, 2022 Direct F1, F4
transaction NASD Common Stock, $0.01 par value Sale -$53K -141 -0.12% $375.56* 119K Nov 16, 2022 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of common stock pursuant to reporting owner's 10b5-1 plan.
F2 This price represents the sale price of the transactions on the reported date at $374.1828. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
F3 This price represents the sale price of the transactions on the reported date at $374.9239. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
F4 This price represents the sale price of the transactions on the reported date at $374.6617. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
F5 This price represents the sale price of the transactions on the reported date at $375.5611. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.